Our Sites use cookies for analytics purposes. For more information about the cookies we use on our Sites or how you can disable them, please see our Cookie Policy.
JAS’ webinar was one of the most anticipated webinar series for pharma and healthcare logistics.
Merck & Co (known as MSD outside of North America), Sonoco ThermoSafe, and JAS are all three very different companies, but they gathered together on February 22, 2022, to discuss the coming era of pharma and healthcare logistics. Moderated by David Bang, EVP Pharma & Healthcare at JAS, the panel consisted of David Komjati, Director Logistics Transformation at Merck & Co, Ben VanderPlas, Director of Engineering and R&D at Sonoco ThermoSafe, and Graeme Robinson, EVP Operations and Product at JAS.
Major disruptions are followed by an accelerated increase or decrease of specific policies, technologies, practices, and even human behaviors. As we are at the pivot point in between the last two years of pandemic and the next years of recovery, the panelists shared how they see the breakdown of the barriers to respond to lack of visibility into inventory status, location, and production process for pharma and healthcare products across the entire ecosystem. Also, practically speaking, we must deal with the upfront challenges such as congestion, capacity, labor shortage, supply shortage, etc. that are expected to continue in 2022 and well into 2023.
Merck & Co has been in the forefront of transformative development using IoT devices, clouds, and other technologies for some time and will share what the next evolution will be at Merck & Co. Sonoco ThermoSafe, from research and engineering perspectives, is working on numerous projects that have themes of sustainability, autonomy, real-time, and integration as well and added nicely how a company like Sonoco ThermoSafe has been navigating so far and is planning to adapt to a new norm.
JAS, as a global logistics provider connecting many dots with data and physical touches, has critical roles to play in the coming years and shared how it is preparing for future disruptions based on lessons learned and how it is reimagining the world of pharma and healthcare logistics in the next few years to come, closely collaborating with customers and partners.